Psyllium: IBS, Constipation and Diarrhoea

Table of Contents

1. In Short
2. How One Fibre Works Both Ways
3. Chronic Constipation: The Pooled Evidence
4. Psyllium Among Over-the-Counter Laxatives
5. Head to Head: Docusate, Prunes and Kiwifruit
6. What Psyllium Does to Gut Bacteria
7. Irritable Bowel Syndrome
8. Loose Stools, Haemorrhoids and Fissures
9. Children and People With Neurological Disease
10. Wind, Bloating and Other Side Effects
11. Key Research Papers
12. Connections

In Short

• Constipation: in a 2022 meta-analysis of 16 trials, psyllium was one of two fibres with significant effects; benefits were clearest above 10 g a day for at least 4 weeks.
• Strength of evidence: graded moderate (B) in a 2021 review of over-the-counter constipation treatments, behind polyethylene glycol and senna (A).
• Against fruit: prunes and kiwifruit did as well or slightly better than psyllium in head-to-head trials, with fewer side effects in one trial.
• IBS: a review found insufficient evidence for fibres other than psyllium.
• Loose stools: its water-holding capacity is the reason it is used to firm stools in fast transit.
• Side effects: flatulence is the main one.

How One Fibre Works Both Ways

McRorie and McKeown's 2017 review of fibre physics states that there are only two mechanisms by which a fibre has a laxative effect in the large bowel:

1. Large, coarse particles of insoluble fibre, such as coarse wheat bran, mechanically irritate the gut lining and stimulate it to secrete water and mucus.
2. A gel-forming soluble fibre with high water-holding capacity, such as psyllium, “resists dehydration” — the colon normally pulls water out of stool, and the gel holds it in.

Both mechanisms need the fibre to survive the colon largely unfermented and still be present in the stool. The review notes that soluble fermentable fibres such as inulin, fructo-oligosaccharides and wheat dextrin do not provide a laxative effect, and that some fibres — wheat dextrin, and fine, smooth wheat bran — can be constipating.

The European Medicines Agency's monograph adds two further details. When taken with enough liquid, the husk swells to increase the volume of bowel contents, creating a stretch stimulus that triggers a bowel movement, while the swollen mucilage forms a lubricating layer. The laxative effect usually begins 12–24 hours after a dose and sometimes peaks after 2–3 days.

The same water-holding gel that softens a hard stool gives body to a watery one. That is the basis of the “normaliser” description.

Chronic Constipation: The Pooled Evidence

The most useful single analysis is a 2022 systematic review and meta-analysis by a King's College London group, published in the American Journal of Clinical Nutrition. It pooled randomised controlled trials of fibre supplements in adults with chronic constipation.

• Trials and people: 16 trials, 1,251 participants.
• Response to treatment: 311 of 473 people (66%) responded to fibre, versus 134 of 329 (41%) on control — a risk ratio of 1.48.
• Which fibres: psyllium and pectin had significant effects.
• Dose: a better response than control was seen only with higher doses (more than 10 g a day).
• Stool frequency: increased with fibre, but only at higher doses and with treatment for 4 weeks or longer.
• Stool consistency: improved, particularly at higher doses.
• Flatulence: higher with fibre than control.

The authors concluded that psyllium, doses above 10 g a day and at least 4 weeks of treatment “appear optimal”, while cautioning that the trials differed considerably. For readers, the practical meaning of these findings is that short trials of small amounts were less likely to show a benefit. The site's Constipation page covers causes and other treatments.

Psyllium Among Over-the-Counter Laxatives

Rao and Brenner's 2021 systematic review in the American Journal of Gastroenterology graded every over-the-counter constipation product with trials of at least four weeks published between 2004 and 2020. Of 1,297 studies identified, 41 met their criteria.

• Good evidence (grade A): polyethylene glycol (an osmotic laxative) and senna (a stimulant).
• Moderate evidence (grade B): psyllium, a second fibre product, magnesium salts, the stimulants bisacodyl and sodium picosulfate, fruit-based laxatives (kiwi, mango, prunes, figs), and a yoghurt combination.
• Insufficient evidence (grade I): polydextrose, inulin and fructo-oligosaccharides.
• Safety: diarrhoea, nausea, bloating and abdominal pain were common adverse events across products, and no serious adverse events were reported.

The review was funded by a pharmaceutical company that sells laxatives, and one author disclosed past grant support from a dried-plum industry body; both disclosures are in the paper. The grading itself followed the US Preventive Services Task Force method. The Senna pages on this site cover the stimulant laxative graded above psyllium, which works by an entirely different mechanism.

Head to Head: Docusate, Prunes and Kiwifruit

Psyllium versus docusate (1998)

In a double-blind trial of 170 people with chronic idiopathic constipation, psyllium 5.1 g twice a day was compared with the stool softener docusate sodium 100 mg twice a day for 2 weeks. Psyllium increased stool water content (2.33% versus 0.01%), stool water weight and total weekly stool output more than docusate, and bowel movements were more frequent with psyllium in the second week (3.5 versus 2.9 a week) but not the first. This trial was run by a psyllium-product manufacturer.

Psyllium versus prunes (2014 review)

A systematic review of prune trials found one trial in constipation: 3 weeks of prunes (100 g a day) improved stool frequency (3.5 versus 2.8 complete bowel movements a week) and stool consistency more than psyllium (22 g a day).

Psyllium versus kiwifruit and prunes (2021)

A partly randomised US trial assigned 79 adults with chronic constipation to two green kiwifruit a day, 100 g of prunes a day, or 12 g of psyllium a day for 4 weeks. All three increased complete bowel movements; the proportion of responders was similar across groups. Psyllium improved straining but not stool consistency. Side effects were most common with psyllium and least common with kiwifruit, and fewer people were dissatisfied with kiwifruit.

Pooled food trials (2024)

A meta-analysis of foods, drinks and diets for constipation found that fruits produced slightly more bowel movements per week than psyllium (+0.36 a week), driven mainly by kiwifruit, with no difference between prunes and psyllium.

Taken together, these trials place psyllium in the same broad range as fruit-based approaches, and ahead of the stool softener docusate. See Prunes: Digestion and Constipation and Kiwifruit.

What Psyllium Does to Gut Bacteria

• Nottingham trials (2019): two small randomised, placebo-controlled, double-blind trials gave psyllium or maltodextrin for 7 days to 8 healthy volunteers and 16 people with constipation. Psyllium increased stool water. It had a small effect on the stool bacteria of healthy people and a larger one in constipated people, including increases in genera such as Lachnospira, Faecalibacterium and Veillonella, and changes in the short-chain fatty acids acetate and propionate. Increases in three butyrate-producing genera correlated with increased stool water.
• Chinese trial (2023): a 4-week double-blind trial in 250 adults with functional constipation compared polydextrose, psyllium husk, wheat bran plus psyllium, a two-strain probiotic, and a maltodextrin placebo (oligosaccharides were added to all four active groups). No group differed from placebo over time in bowel movement frequency, stool form score or straining, but stool form improved within each active group and not within placebo. The genus Anaerostipes increased in both psyllium groups and was associated with more frequent bowel movements. The supplements were provided by a supplement company.
• Mexican trial (2024): a secondary analysis of 20 patients given agave fructans or psyllium measured gut transit with a swallowed wireless capsule. Clinical response and stool consistency were similar across groups, but neither transit time, gut contractions nor colonic pH changed, suggesting fibre helps by other routes.

A 2013 review of fibre and prebiotics lists psyllium among fibres with prebiotic effects, though not among those meeting every part of the formal prebiotic definition.

Irritable Bowel Syndrome

Fibre in IBS has a mixed history: some fibres make bloating and pain worse. Psyllium is the exception that the literature keeps returning to.

• A 2017 review of diet in IBS by a King's College London group found “insufficient evidence of the effect of fibres other than psyllium in IBS”, while noting that a low-FODMAP diet benefits a majority of patients and that more research on different fibres is needed.
• A Monash University review of what to do when a low-FODMAP diet does not work describes psyllium's “exceptional water-holding capacity” as the reason it is tried to promote more formed stools in people with fast transit.
• The EMA monograph lists ispaghula husk as an adjuvant in constipation-predominant IBS (EMA).

The physics review explains part of the contrast: psyllium works as a water-holding gel rather than as food for gut bacteria, whereas the fibres that disappointed in IBS are largely fermentable. More on the condition is in Irritable Bowel Syndrome, Low-FODMAP Diet for IBS and Peppermint, Probiotics and Herbals.

Loose Stools, Haemorrhoids and Fissures

The fast-transit reasoning above extends to loose stools in general: a gel that holds water gives stool more form. Direct trial evidence for psyllium in diarrhoea is less extensive than for constipation, and the pack of studies used for this page does not include a diarrhoea trial, so no effect size is given here. Persistent diarrhoea has many causes, some serious; the Chronic Diarrhea page describes them. One cause worth knowing in people with IBS-D is bile acid malabsorption, covered on the Bile Acid Malabsorption page.

The EMA monograph lists a second “well-established” indication: conditions in which easy passage of a soft stool is desirable, such as painful bowel movements after rectal or anal surgery, anal fissures, and haemorrhoids. The reasoning is mechanical — less straining over a softer, bulkier stool. See Hemorrhoids.

Children and People With Neurological Disease

Children

A 2021 review of non-drug approaches to childhood constipation by paediatric gastroenterologists from several US children's hospitals found that data were sparse. It reported that fibre supplements such as glucomannan and some fibre blends have emerging evidence in children, but that “evidence for psyllium, cellulose and flaxseed only have supportive studies in adults”. The EMA monograph lists a lower dose for children aged 6–12 and does not recommend use under 6 years.

Neurological disease

People with multiple sclerosis, spinal cord injury, Parkinson's disease and similar conditions have high rates of both constipation and faecal incontinence. A 2024 Cochrane review of 25 studies included psyllium among a group of “conservative interventions” (alongside nursing approaches, probiotics and others). Those interventions as a group may improve constipation, but the evidence was low-certainty, the studies were generally at high risk of bias, and the review could not isolate psyllium's own effect. The authors described the evidence base as “almost uniformly of low methodological quality”.

Wind, Bloating and Other Side Effects

• Flatulence was significantly more common with fibre than control in the 2022 meta-analysis; the EMA notes that it generally fades as treatment continues.
• Side effects compared with fruit: in the 2021 US trial, adverse events were most common with psyllium and least common with kiwifruit.
• Across over-the-counter products: diarrhoea, nausea, bloating and abdominal pain were common, with no serious adverse events reported in the 2021 review.
• Blockage: the EMA lists abdominal distension and a risk of intestinal or oesophageal obstruction and faecal impaction, “particularly if swallowed with insufficient fluid”, and lists faecal impaction with abdominal pain, nausea and vomiting as reasons it is not used without medical advice (EMA).

These and the allergy findings are set out in Psyllium: Allergy, Choking and Drug Timing.

Key Research Papers

1. van der Schoot A, Drysdale C, Whelan K, et al. The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American journal of clinical nutrition. 2022;116(4):953-969. — 16 trials, 1,251 adults; psyllium and pectin effective; above 10 g/day for 4+ weeks; more flatulence. PubMed PMID: 35816465
2. Rao SSC, Brenner DM. Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. The American journal of gastroenterology. 2021;116(6):1156-1181. — 41 trials; psyllium graded B; polyethylene glycol and senna graded A; industry-funded review. PubMed PMID: 33767108
3. McRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Alimentary pharmacology & therapeutics. 1998;12(5):491-7. — 170 adults; psyllium beat docusate on stool water and output; manufacturer-run. PubMed PMID: 9663731
4. Lever E, Cole J, Scott SM, et al. Systematic review: the effect of prunes on gastrointestinal function. Alimentary pharmacology & therapeutics. 2014;40(7):750-8. — prunes improved stool frequency more than psyllium in one constipation trial. PubMed PMID: 25109788
5. Chey SW, Chey WD, Jackson K, et al. Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation. The American journal of gastroenterology. 2021;116(6):1304-1312. — 79 adults; kiwifruit, prunes and psyllium all helped; side effects most common with psyllium. PubMed PMID: 34074830
6. Van Der Schoot A, Katsirma Z, Whelan K, et al. Systematic review and meta-analysis: Foods, drinks and diets and their effect on chronic constipation in adults. Alimentary pharmacology & therapeutics. 2024;59(2):157-174. — fruits slightly ahead of psyllium on weekly bowel movements; prunes no different. PubMed PMID: 37905980
7. McRorie JW Jr, McKeown NM. Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber. Journal of the Academy of Nutrition and Dietetics. 2017;117(2):251-264. — the two mechanisms by which fibres act as laxatives. PubMed PMID: 27863994
8. Jalanka J, Major G, Murray K, et al. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls. International journal of molecular sciences. 2019;20(2). — psyllium increased stool water and shifted gut bacteria, more in constipated patients. PubMed PMID: 30669509
9. Lai H, Li Y, He Y, et al. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut microbes. 2023;15(1):2197837. — 250 adults; fibre or probiotic groups improved stool form within group; no time-by-group effect. PubMed PMID: 37078654
10. Coss-Adame E, Arenas-Martínez JS, García-Cedillo MF, et al. The effect of fiber supplementation with agave fructans or psyllium plantago in symptoms of constipation and its relation with whole and regional transit time and pH. Neurogastroenterology and motility. 2024;36(11):e14908. — 20 patients; clinical response without change in transit time. PubMed PMID: 39223790
11. Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current opinion in clinical nutrition and metabolic care. 2017;20(6):456-463. — insufficient evidence for fibres other than psyllium in IBS. PubMed PMID: 28872467
12. Halmos EP. When the low FODMAP diet does not work. Journal of gastroenterology and hepatology. 2017;32 Suppl 1:69-72. — psyllium's water-holding capacity used for fast-transit IBS. PubMed PMID: 28244666
13. Santucci NR, Chogle A, Leiby A, et al. Non-pharmacologic approach to pediatric constipation. Complementary therapies in medicine. 2021;59:102711. — psyllium evidence in constipation comes from adults, not children. PubMed PMID: 33737146
14. Todd CL, Johnson EE, Stewart F, et al. Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central neurological diseases. The Cochrane database of systematic reviews. 2024;10(10):CD002115. — Cochrane: conservative measures including psyllium, low-certainty evidence in neurological disease. PubMed PMID: 39470206
15. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417-35. — psyllium listed among fibres with prebiotic effects. PubMed PMID: 23609775

PubMed Topic Searches

1. Psyllium and chronic constipation
2. Psyllium in irritable bowel syndrome
3. Psyllium and diarrhoea
4. Psyllium and haemorrhoids or anal fissure

Back to Table of Contents

Connections

• Psyllium (Plantago ovata) — the main page
• Psyllium: Benefits Deep Dive — the evidence hub
• Cholesterol and Heart Health — the lipid evidence
• Blood Sugar and Diabetes — the glucose evidence
• Allergy, Choking and Drug Timing — the hazards
• Digestive and Gut Herbs — the category
• Constipation — the symptom and its causes
• Natural Constipation Relief — non-drug approaches
• Irritable Bowel Syndrome — the condition
• Low-FODMAP Diet for IBS — the diet psyllium is often paired with
• Hemorrhoids — one of the EMA indications
• Diverticulitis — another bowel condition linked to fibre
• Senna — the stimulant laxative graded A
• Prunes: Digestion and Constipation — the fruit comparator
• Kiwifruit — the other fruit comparator
• Dietary Fiber — fermentable versus gel-forming fibre

Back to Table of Contents